The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2015

Filed:

Jul. 10, 2012
Applicants:

Sylvain Juge, Dijon, FR;

Jerome Bayardon, Dijon, FR;

Emmanuelle Remond, Mailleroncourt-Charette, FR;

Hugo Laureano, Dijon, FR;

Jean-christophe Henry, Nancy, FR;

Frederic Leroux, Herrlisheim, FR;

Francoise Colobert, Lampertheim, FR;

Inventors:

Sylvain Juge, Dijon, FR;

Jerome Bayardon, Dijon, FR;

Emmanuelle Remond, Mailleroncourt-Charette, FR;

Hugo Laureano, Dijon, FR;

Jean-Christophe Henry, Nancy, FR;

Frederic Leroux, Herrlisheim, FR;

Francoise Colobert, Lampertheim, FR;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07F 17/02 (2006.01); C07F 9/50 (2006.01); C07F 9/54 (2006.01); C07B 53/00 (2006.01); B01J 31/22 (2006.01); C07F 15/00 (2006.01); C07B 37/04 (2006.01);
U.S. Cl.
CPC ...
B01J 31/2295 (2013.01); B01J 31/2286 (2013.01); C07B 37/04 (2013.01); C07B 53/00 (2013.01); C07F 9/50 (2013.01); C07F 9/5022 (2013.01); C07F 9/5027 (2013.01); C07F 9/5072 (2013.01); C07F 9/54 (2013.01); C07F 15/00 (2013.01); C07F 15/0073 (2013.01); C07F 17/02 (2013.01);
Abstract

Novel P-chirogenic organophosphorus compounds of general formula (I), a process for the synthesis of the compounds of formula (I), and intermediate products of general formulae (II), (III) and (IV), as shown below, are involved in the synthesis of compounds (I). Metal complexes including compounds (I) as ligands are also described. The novel compounds and complexes are useful in asymmetric catalysis by transition metal complexes or organocatalysis, especially for asymmetric hydrogenation or allylation. Compounds of general formula (I) may be useful as agrochemical and therapeutic substances, or as reagents or intermediates for fine chemistry.


Find Patent Forward Citations

Loading…